A 16,000.00-share volume spike drove trading in CRCC.CN stock during market hours on 28 Feb 2026, testing liquidity in the small-cap cannabis investor Copland Road Capital Corporation on the CNQ exchange in Canada. The stock held at C$0.13, matching the session high and close. This volume is 39.31x the 50-day average and signals renewed trader interest rather than fundamental news. As an AI-powered market analysis platform, Meyka AI is tracking the move and layering valuation, technicals, and a model forecast to frame next steps for investors.

CRCC.CN stock price and volume spike

CRCC.CN stock traded between C$0.13 high and C$0.125 low during market hours on 28 Feb 2026, with 16,000.00 shares changing hands versus an average daily volume of 407.00. That jump to a relative volume of 39.31 signals a clear volume spike. The market cap is C$1,438,905.00 and shares outstanding are 11,068,500.00, so even modest flows can move the price. We link the trading to a liquidity test and short-term positioning rather than a confirmed earnings or corporate update source.

CRCC.CN stock valuation and financials

On fundamentals, Copland Road Capital Corporation shows EPS -0.05 and a negative P/E at -2.60, reflecting recent losses. Book value per share is C$0.05 and price-to-book is 2.51, while cash per share is C$0.03. The current ratio is 15.37, indicating short-term liquidity, and operating cash flow per share is -0.01. These metrics point to a capital-light, investment holding company with weak profitability but ample current assets relative to liabilities.

Technicals, momentum and Meyka AI stock grade for CRCC.CN stock

Technicals show price average 50 at C$0.14 and 200 at C$0.17 with Bollinger Bands top C$0.14 and bottom C$0.12. Momentum indicators are muted but ADX registers 100.00, reflecting a decisive short-term trend tied to volume. Meyka AI rates CRCC.CN with a score out of 100: 63.42 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

CRCC.CN stock sector context and catalysts

Copland Road Capital sits in the Healthcare sector under Drug Manufacturers – Specialty & Generic but operates as an investment vehicle focused on cannabis opportunities in the U.S. The healthcare sector median P/E is 32.71, so CRCC.CN’s negative P/E stands out. Catalysts that could move the stock include portfolio exits, equity raises, or new majority-stake investments by Copland Road. For comparator activity and market commentary see the industry comparison source.

CRCC.CN stock liquidity, risks and short-term trade setup

The volume spike lifted liquidity but risk remains elevated: market cap C$1,438,905.00, low free float, and negative earnings increase volatility. Price averages and cash buffers reduce immediate solvency risk, yet dependency on equity deals or asset sales is real. Short-term traders can use the C$0.12–C$0.14 band as a range, watching volume persistence; failure to hold C$0.125 would increase downside probability.

CRCC.CN stock price target and Meyka AI forecast

Meyka AI’s forecast model projects monthly C$0.19 and yearly C$0.17 (exact: C$0.16573). Against the current price of C$0.13, the yearly projection implies a 27.57% upside to C$0.16573. Short-term traders might set a conservative target near C$0.19 if volume continues, with a downside support near the year low C$0.125. Forecasts are model-based projections and not guarantees.

Final Thoughts

The volume spike to 16,000.00 shares during market hours on 28 Feb 2026 put CRCC.CN stock back on watch lists. At C$0.13, the stock shows thin-market dynamics: a market cap of C$1,438,905.00, EPS -0.05, and price-to-book 2.51. Meyka AI’s forecast model projects a yearly price of C$0.16573, implying a 27.57% upside from today’s level. Our Meyka grade (score 63.42, Grade B, Suggestion: HOLD) reflects mixed signals: strong short-term liquidity metrics but weak profitability and reliance on portfolio activity. Traders should monitor follow-through volume above 16,000.00 shares and any company announcements on investments or equity actions. Remember these are model-based projections and not guarantees; consider position sizing and liquidity risk when trading CRCC.CN stock. For more detail visit our Meyka stock page for CRCC.CN and company filings at Copland Road’s site.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.